PYLORI-CHEK BREATH TEST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pylori-chek Breath Test, and when can generic versions of Pylori-chek Breath Test launch?
Pylori-chek Breath Test is a drug marketed by Dxs Devices and is included in one NDA.
The generic ingredient in PYLORI-CHEK BREATH TEST is urea c-13. There are thirty-three drug master file entries for this compound. Additional details are available on the urea c-13 profile page.
Summary for PYLORI-CHEK BREATH TEST
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Clinical Trials: | 112 |
Patent Applications: | 99 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PYLORI-CHEK BREATH TEST at DailyMed |
Recent Clinical Trials for PYLORI-CHEK BREATH TEST
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Peking University Care Luzhong Hospital | Phase 4 |
Yuncheng County Hospital of Traditional Chinese Medicine | Phase 4 |
People's Hospital of Zhengzhou University | Phase 4 |
US Patents and Regulatory Information for PYLORI-CHEK BREATH TEST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dxs Devices | PYLORI-CHEK BREATH TEST | urea c-13 | FOR SOLUTION;ORAL | 020900-001 | Feb 4, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |